Sexual minorities are at elevated risk of cardiovascular disease from a younger age than heterosexuals

2022 ◽  
Author(s):  
Jessica Sherman ◽  
Christina Dyar ◽  
Jodi McDaniel ◽  
Nicholas T. Funderburg ◽  
Karen M. Rose ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Sexual Minorities ◽  
Elevated Risk ◽  
Younger Age

scholarly journals A CRITICAL REVIEW OF VATIKA HRIDROGA WITH SPECIAL REFERENCE TO ISCHEMIC HEART DISEASE

2022 ◽  
Vol 12 (6) ◽  
pp. 69-72
Author(s):  
Anchal Jaiswal ◽  
Sanjay Kumar Singh ◽  
Seema Joshi
Keyword(s):  
Cardiovascular Disease ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
The Other ◽  
Ischemic Heart ◽  
Detailed Knowledge ◽  
Age Group ◽  
Disease Entity ◽  
Younger Age ◽  
Day By Day

Given increasing evidence, most deaths are due to non-communicable diseases; half of them are the cardiovascular disease. Hridaya is moolasthana of pranvavaha and rasavaha strotas. According to Acharya Sushruta, any condition that produces disturbance in the heart is Hridroga. It is classified into five types. Vataja Hridroga is characterized by Ruja in Urah Pradesha (Pain in the chest region). Vatika type seems to have conceived the disease entity correlated with ischemic heart disease. None of the other Cardiac afflictions appears to have been described under Hridroga. The prevalence rate in the younger age group is increasing day by day so, we need to know the detailed knowledge of vatika hridroga

Abstract P283: Disparities in Long-term Risk of Cardiovascular Disease by Sexual Orientation and Race/Ethnicity: the National Longitudinal Study of Adolescent Health

Circulation ◽  
2014 ◽  
Vol 129 (suppl_1) ◽  
Author(s):  
Cari J Clark ◽  
Iris W Borowsky ◽  
Alvaro Alonso ◽  
Rachael A Spencer ◽  
Susan A Everson-Rose
Keyword(s):  
Cardiovascular Disease ◽  
Sexual Orientation ◽  
Longitudinal Study ◽  
Adolescent Health ◽  
Sexual Minorities ◽  
P Value ◽  
Cvd Risk ◽  
National Longitudinal Study ◽  
Increased Risk ◽  
Race Ethnicity

Background: Risk of cardiovascular disease (CVD) may be higher in sexual minorities, but epidemiologic evidence is sparse. We used a nationally representative sample of young adults to examine sex-specific disparities in global CVD risk by sexual orientation and race/ethnicity. Methods: Data were from National Longitudinal Study of Adolescent Health subjects who participated in wave 4 (2008-09) and who had valid weights and non-missing data (7087 women; 6340 men). Age, race/ethnicity, sexual orientation, education, financial stress, and CVD risk factors (body mass index, smoking, diabetes, systolic blood pressure, and use of antihypertensive medication) were collected via an in-home interview. We calculated the 30-Year risk for total CVD using a Framingham-based prediction model. Sex-specific differences in 30-year risk of CVD by sexual orientation were calculated with weighted linear models adjusted for age, race/ethnicity, education, and financial distress. Sex-specific interactions between race/ethnicity and sexual orientation were tested. Results: Mean age was 28.9 ± .2 years; 93% (n=5912) of male participants were heterosexual, 4% (n=258) were bisexual, and 2% (n=170) were gay. 80% (n=5713) of female participants were heterosexual, 18% (n=1243) were bisexual, and 2% (n=131) were lesbian. Average 30-year risk of CVD was 17.2 ± .5% in men and 9.0 ± .3% in women. Differences in CVD risk by sexual orientation were not detectable for men (p=.59). Compared to heterosexual women, bisexual and lesbian women had a .9% (95% CI: .3, 1.4) and 2.0% (95% CI: .7, 3.2) higher risk of CVD, respectively. In race/ethnicity stratified models (interaction p-value=.01), an increased risk among sexual minorities, especially lesbians, was detectable except among Hispanic women (Figure). Conclusion: Disparities in global CVD risk were observed by sexual orientation for women and persisted across most racial/ethnic groups. Sexual orientation may be a marker of increased risk of CVD but more research on contributing factors is needed.

The effect of exercise and diet on mental health and quality of life in middle-aged individuals with elevated risk factors for cardiovascular disease

1999 ◽  
Vol 17 (5) ◽  
pp. 369-377 ◽  
Author(s):  
MARIT SORENSEN ◽  
SIGMUND ANDERSSEN ◽  
INGVAR HJERMAN ◽  
INGAR HOLME ◽  
HOLGER URSIN
Keyword(s):  
Quality Of Life ◽  
Mental Health ◽  
Risk Factors ◽  
Cardiovascular Disease ◽  
Elevated Risk ◽  
Middle Aged

scholarly journals Ventricular Ectopy and Arrhythmia Characteristics for Persons Living with HIV and Uninfected Controls

2019 ◽  
Vol 18 ◽  
pp. 232595821985212
Author(s):  
Alexander Meyer ◽  
Sanjay Dandamudi ◽  
Chad Achenbach ◽  
Donald Lloyd-Jones ◽  
Matthew Feinstein
Keyword(s):  
Cardiovascular Disease ◽  
Chart Review ◽  
International Classification Of Diseases ◽  
Elevated Risk ◽  
Ventricular Ectopy ◽  
Persons Living With Hiv ◽  
Significant Difference ◽  
Classification Of Diseases ◽  
Living With Hiv

Background: Persons with HIV have elevated risk for cardiovascular disease, but little is known about the risk of ventricular ectopy and ventricular tachycardia (VE/VT) for HIV-infected (HIV+) persons. Methods: We evaluated the presence and anatomic origin of VE/VT for HIV+ persons and controls by screening a cohort using International Classification of Diseases codes and adjudicating positive screens by chart review. We sought to evaluate (1) presence of VE/VT and (2) likely anatomic origin of the VE/VT based on electrocardiogram. Results: There was no significant difference in the prevalence of VE/VT for HIV+ or uninfected persons. Among HIV+ persons, worse HIV control was associated with significantly greater odds of VE/VT. Exploratory analyses suggested that HIV+ persons may have a greater likelihood of VE/VT originating from the left ventricle. Conclusion: Although worse HIV control was associated with higher odds of VE/VT among persons with HIV, odds of VE/VT were not higher for persons with HIV than uninfected persons.

Prehypertension and Elevated Risk of Cardiovascular Disease: Physiopathologic Mechanisms

2007 ◽  
Vol 120 (4) ◽  
pp. e11 ◽  
Author(s):  
Flora Affuso ◽  
Antonio Ruvolo ◽  
Serafino Fazio
Keyword(s):  
Cardiovascular Disease ◽  
Elevated Risk

scholarly journals Recent trends in cardiovascular disease deaths: a state specific perspective

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Sheila M. Manemann ◽  
Yariv Gerber ◽  
Suzette J. Bielinski ◽  
Alanna M. Chamberlain ◽  
Karen L. Margolis ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Cerebrovascular Disease ◽  
National Level ◽  
Early Time ◽  
The State ◽  
Hospital Death ◽  
Mortality Trends ◽  
Online Data ◽  
Younger Age ◽  
Cvd Mortality

Abstract Background The rate of decline in cardiovascular disease (CVD) mortality has lessened nationally. How these findings apply to specific states or causes of CVD deaths is not known. Examining these trends at the state level is important to plan local interventions. Methods We analyzed CVD mortality trends in Minnesota (MN) using the U.S. Centers for Disease Control and Prevention (CDC) Wide-ranging ONline Data for Epidemiologic Research (WONDER). Trends were analyzed by age, sex, type of CVD and location of death. Results CVD mortality rates in MN declined in 2000–2009 and then leveled off in 2010–2018, paralleling national rates. Age- and sex-adjusted CVD mortality decreased by 3.7% per year in 2000–2009 (average annual percent changes [AAPC]: -3.7; 95% CI: − 4.8, − 2.6) with no change observed in 2010–2018. Those aged 65–84 years had the most rapid early decline in CVD mortality (AAPC: -5.9, 95% CI: − 6.2, − 5.7) and had less improvement in 2010–2018 (AAPC: -1.8, 95% CI: − 2.2, − 1.5), and the younger age group (25–64 years) now experiences the most adverse trends (AAPC: 1.2, 95% CI: 0.7–1.8). Coronary heart disease (CHD) and cerebrovascular disease had the largest relative decreases in mortality in 2000–2009 (CHD AAPC: -5.2; 95% CI: − 6.5,-3.9; cerebrovascular disease AAPC: -4.4, 95% CI: − 5.2, − 3.6) with no change 2010–2018. Heart failure (HF)/cardiomyopathy followed similar trends with a 2.5% decrease (AAPC 95% CI: − 3.5, − 1.5) per year in 2000–2009 and no change in 2010–2018. Deaths from other CVD also decreased in the early time period (AAPC: -1.6, 95% CI: − 2.7, − 0.5) but increased in 2010–2018 (AAPC: 1.9, 95% CI: 0.5, 3.3). In- and out-of-hospital death rates improved in 2000–2009 with a slowing in improvement for in-hospital death and no further improvement for out-of-hospital death in 2010–2018. Conclusion Concerning CVD mortality trends occurred in MN. In the most recent decade (2010–2018) mortality from all CVD subtypes plateaued or even increased. CVD mortality among the younger age groups increased as well. These data are congruent with adverse national trends supporting their generalizability. These adverse trends underscore the urgent need for CVD prevention and treatment, as well as continued surveillance to assess progress at the state and national level.

Sign in / Sign up

Export Citation Format

Share Document